Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls

The study assessed long-term immunopersistence and safety of the Escherichia coli (E. coli)-produced HPV-16/18 bivalent vaccine. In total, 979 participants in the initial immunogenicity noninferiority study, including girls aged 9-14 years who were randomized in a 1:1 ratio to receive 2 doses at mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xingmei, He, Wengang, Wu, Xianghong, Gu, Jianxiang, Zhang, Jing, Lin, Bizhen, Bi, Zhaofeng, Su, Yingying, Huang, Shoujie, Hu, Yuemei, Wu, Ting, Zhang, Jun, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
HPV – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897638/
https://www.ncbi.nlm.nih.gov/pubmed/35417301
http://dx.doi.org/10.1080/21645515.2022.2061248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897638/
https://www.ncbi.nlm.nih.gov/pubmed/35417301
http://dx.doi.org/10.1080/21645515.2022.2061248

Ejemplares similares